Board meeting to approve Q2 and half-year results

Results View source PDF Explain this filing

WANBURY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.0%Reaction day

₹176.80

prior close

₹174.16

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Pharmaceuticals peers, median of 170sector+0.6%-2.6% vs sector

On the reaction day the stock moved 2.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.0pendingpending+0.6-2.6

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Wanbury Limited has scheduled a Board meeting for November 4, 2026 to approve its unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2026. The filing provides no financial figures. Insider trading remains closed until 48 hours after results are declared.

Likely market impact

No results are disclosed yet, so key performance signals remain unknown. Insider trading stays closed until 48 hours after the announcement.